In glaucoma, microglial activation and an inflammatory response involving Toll-like receptors (TLRs), complement molecules and cytokines, such as TNFα and IL-1β, is associated with secondary phase of the disease [41]. The gene discussed is IL1B; the disease is glaucoma.